📊 BSPK Key Takeaways
Investment Thesis
Bespoke Extracts is in severe financial distress with negative stockholders' equity of -$2.6M, indicating liabilities exceed assets by a significant margin. Despite 42.3% revenue growth, the company is deeply unprofitable with a -48.5% net margin, burning cash at an alarming rate (-$723.6K free cash flow) while maintaining minimal liquidity (0.11x current ratio). The combination of deteriorating financial position, negative equity, and unsustainable cash burn presents an extreme capital structure risk.
BSPK Strengths
- Revenue growth of 42.3% year-over-year demonstrates market traction
- Gross margin of 48.4% suggests underlying product economics are viable
- Some improvement in diluted EPS despite continued losses
BSPK Risks
- Negative stockholders' equity of -$2.6M indicates insolvency risk and potential total loss for equity holders
- Critically low liquidity ratios (0.11x current ratio, 0.07x quick ratio) with only $16.7K cash against $2.9M liabilities
- Severe cash burn with -$123.6K operating cash flow and -$723.6K free cash flow unsustainable without immediate capital injection
- Operating margin of -41.1% with $461.2K operating loss shows inability to scale profitably
- High capex of $600K relative to $1.1M revenue suggests investment-phase company without path to profitability
Key Metrics to Watch
- Stockholders' equity trajectory - critical threshold is returning to positive territory
- Operating cash flow - must stabilize and turn positive within 1-2 quarters
- Gross margin sustainability - watch for pricing pressure or cost inflation
- Burn rate relative to cash runway - current trajectory suggests imminent liquidity crisis
BSPK Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BSPK Profitability Ratios
BSPK vs Healthcare Sector
How Bespoke Extracts, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
BSPK Balance Sheet & Liquidity
BSPK 5-Year Financial Trend
5-Year Trend Summary: Bespoke Extracts, Inc.'s revenue has grown significantly by 6,920% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.15 indicates the company is currently unprofitable.
BSPK Growth Metrics (YoY)
BSPK Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $277.5K | -$78.1K | $-0.01 |
| Q2 2025 | $278.2K | -$205.1K | $-0.02 |
| Q1 2025 | $260.4K | -$260.5K | $-0.02 |
| Q3 2024 | $244.4K | -$275.6K | $-0.03 |
| Q2 2024 | $188.2K | -$260.9K | $-0.03 |
| Q1 2024 | $89.0K | -$314.1K | $-0.03 |
| Q3 2023 | $3.4K | -$301.5K | $-0.01 |
| Q2 2023 | $346 | -$464.9K | $-0.05 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
BSPK Capital Allocation
BSPK SEC Filings
Access official SEC EDGAR filings for Bespoke Extracts, Inc. (CIK: 0001409197)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BSPK
What is the AI rating for BSPK?
Bespoke Extracts, Inc. (BSPK) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are BSPK's key strengths?
Revenue growth of 42.3% year-over-year demonstrates market traction. Gross margin of 48.4% suggests underlying product economics are viable.
What are the risks of investing in BSPK?
Negative stockholders' equity of -$2.6M indicates insolvency risk and potential total loss for equity holders. Critically low liquidity ratios (0.11x current ratio, 0.07x quick ratio) with only $16.7K cash against $2.9M liabilities.
What is BSPK's revenue and growth?
Bespoke Extracts, Inc. reported revenue of $1.1M.
Does BSPK pay dividends?
Bespoke Extracts, Inc. does not currently pay dividends.
Where can I find BSPK SEC filings?
Official SEC filings for Bespoke Extracts, Inc. (CIK: 0001409197) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BSPK's EPS?
Bespoke Extracts, Inc. has a diluted EPS of $-0.05.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.